An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment

Trial locations(27 sites)

United States

UC Davis, Sacramento, California

University of Florida, Gainesville, Florida

University of Minnesota Medical Center, Minneapolis, Minnesota

Washington University School of Medicine, St Louis, Missouri

Belgium

UZ Leuven Gasthuisberg, Leuven

Canada

The Hospital for Sick Children, Toronto, Ontario

McGill University Health Center, Montreal, Quebec

Colombia

IPS SURA Industriales Medellín, Medellín

France

Hopital Claude Huriez - CHU Lille, Lille

Groupe Hospitalier Necker Enfants Malades, Paris

Germany

Universitätsklinikum Bonn, Bonn

Gerinnungszentrum Rhein-Ruhr;Gerinnungsambulanz, Duisburg

Hämophiliezentrum Med. Klinik III/Institut für Transfusionsmedizin, Frankfurt/M.

Italy

Universita' Degli Studi La Sapienza-Ist.Di Ematologia, Rome, Lazio

IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Lombardy

AOU Careggi, Florence, Tuscany

Japan

Kurume University Hospital, Fukuoka

Tokyo Medical University Hospital, Tokyo

Netherlands

Erasmus MC, Rotterdam

Poland

Instytut Hematologii i Transfuzjologii, Warsaw

South Africa

Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg

Spain

Hospital Universitario la Paz, Madrid

Hospital Universtiario Virgen del Rocio, Seville

Sweden

Sahlgrenska Universitetssjukhuset, Gothenburg

United Kingdom

St Thomas' Hospital, London

Great Ormond Street Hospital, London

Manchester Royal Infirmary, Manchester